Medical & Healthcare
Phantomics Inc.

Phantomics Inc. is a Korean medical AI company specializing in AI-powered cardiovascular diagnostic solutions. Founded in 2021 and headquartered in Seoul, Korea, Phantomics develops software-as-a-medical-device (SaMD) that empowers clinicians to diagnose heart disease faster, more accurately, and non-invasively.

Our flagship products -- Myomics (AI-based Cardiac MRI Solution) and Angiomics (AI-based Cardiac CT Triage Solution) -- are deployed in 20+ hospitals in Korea, including Korea's BIG 5, and 19 top-tier hospitals across 5 countries.

Myomics holds regulatory clearances in Korea (MFDS), the United States (FDA 510(k)), Japan, Thailand, Taiwan, and Malaysia, with Singapore (HSA) and CE Marking in progress. Angiomics has received Class III medical device approval from Korea's MFDS. The company is a CES 2024 Innovation Award Winner and FIX 2024 Best Innovation Award recipient, and has received top ratings in NICE Technology Assessment.

Cardiac MRI Analysis Solution Cardiac CT Triage Solution

Products

Myomics Image 1

Myomics

Cardiac MRI Analysis Solution

Brochure
Korea (MFDS Class II) USA (FDA 510k) Japan (PMDA) Thailand (FDA Thailand) Taiwan (TFDA) Malaysia (MDA) Singapore (HSA -- In Progress) EU (CE Class IIa - In Progress)
Size N/A (Software)
Weight N/A (Software) HS Code N/A (Software)
Key Specifications ¡Û Function, Mapping (T1/T2) ¡Û Tissue Characterization (LGE) ¡Û Perfusion ¡Û Flow ¡Û Research ¡Û ZERO-click Automation ¡Û DICOM/PACS Integration ¡Û GE Healthcare Compatible ¡Û On-premise PC-installed ¡Û English UI ¡Û Local Language Report Available
Applicatioon Areas Cardiology departments and radiology centers equipped with MRI scanners; academic hospitals and tertiary care centers.

Myomics is an AI-powered Cardiac MRI analysis solution that automates the full workflow of cardiac MRI interpretation -- from image acquisition to diagnostic reporting -- with zero clicks. Traditionally, cardiac MRI analysis requires more than 30 minutes of expert involvement per patient. Myomics reduces this to under 5 minutes through fully automated AI analysis, delivering standardized, reproducible results that integrate seamlessly with existing hospital PACS systems via DICOM. Key Features: o Function: LV/RV automatic analysis, Wall Motion & Thickening, HCM diagnosis, Strain analysis o Mapping: Native T1, Post T1 & T2 Map generation, Synthetic Hematocrit, ECV Map, Z-score standardization o Tissue Characterization: LGE/DE MRI analysis, Hyper-enhanced region quantification, Synthetic LGE generation o Perfusion: Rest & Stress perfusion analysis, Quantitative perfusion, Polar Map & SI Curve o Flow: Phase contrast analysis, Flow & Velocity assessment o Research: Multi-scanner standardization, Radiomics, Easy data sharing Myomics is compatible with all MRI vendors, and is deployed in 50+ hospitals globally, including Korea's BIG 5 academic medical centers. The solution is available as an on-premise PC-installed software with annual subscription licensing.

Angiomics Image 1

Angiomics

Cardiac CT Triage Solution

Brochure
Korea (MFDS) Class III
Size N/A (Software)
Weight N/A (Software) HS Code N/A (Software)
Application Areas Emergency departments, Cardiology departments and radiology centers and cardiac CT centers in hospitals. Particularly suited for institutions with limited after-hours cardiology coverage.

Angiomics is an AI-based Cardiac CT Triage Solution that enables rapid diagnosis of acute coronary artery disease - reducing CT interpretation time from the conventional 1-3 hours to under 10 minutes. By automatically reconstructing coronary CT scans into 3D and segmenting major coronary arteries (LAD, LCX, RCA), Angiomics detects stenosis exceeding 50% with high accuracy. It generates automated curved multi-planar reconstruction (cMPR) images, AI diagnostic summaries, and treatment-direction recommendations - fully integrated with existing hospital PACS systems. Key Features: o Automated coronary artery segmentation and 3D reconstruction (LAD, LCX, RCA) o Stenosis detection (>50%) with AI-assisted triage classification o Curved & Straightened MPR auto-generation (Cardiac Multi View) o AI diagnostic summary report with clinical recommendation and suggested action o Seamless PACS/EMR integration; AHA guideline-compliant triage output Designed for emergency settings where cardiologists may not be immediately available, Angiomics enables evidence-based admission or safe discharge decisions within the critical golden hour.

Certifications

  • Korea (MFDS Class II)
  • USA (FDA 510k)
  • Japan (PMDA)
  • Thailand (FDA Thailand)
  • Taiwan (TFDA)
  • Malaysia (MDA)
  • Singapore (HSA -- In Progress)
  • EU (CE Class IIa - In Progress)

COMPANY INFORMATION

Interested in this company?

Send your inquiry and we will connect you with this company.

Send inquiry